| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9999d359590090d93af9785ab9501e0 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 |
| filingDate |
2017-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb440f75ae74c4cecea927694752b7b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2912e36a857b26d5333a85013b0897e |
| publicationDate |
2018-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2018177658-A |
| titleOfInvention |
Treatment of castration resistant prostate cancer |
| abstract |
PROBLEM TO BE SOLVED: To provide a novel and promising treatment strategy for castration resistant prostate cancer. A castration resistant prostate cancer therapeutic agent is provided, which comprises an RNA targeting the androgen receptor variant AR-V7 or a compound that induces the expression thereof. Also provided is a method of predicting the risk of developing or exacerbating castration resistant prostate cancer, using a specific microRNA as an index. Furthermore, a screening method is provided using a specific microRNA as an indicator. 【Selection chart】 None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020138370-A1 |
| priorityDate |
2017-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |